Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Abstract Background Efficacy and safety of human monoclonal antibody erenumab used for migraine prophylaxis have been shown in clinical studies. APOLLON is an open-label, multi-center, single arm study, which permits dose adjustments of erenumab and includes an option for a drug holiday. The finding...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2024-09-01
|
| Series: | The Journal of Headache and Pain |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s10194-024-01860-w |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|